Studies on catecholamines, renin and aldosterone following Catapresan (2-(2,6-dichlor-phenylamine)-2-imidazoline hydrochloride) in hypertensive patients.
D000293:Adolescent; D000328:Adult; D000368:Aged; D000450:Aldosterone / Q000652:urine*; D000959:Antihypertensive Agents / Q000008:administration & dosage / Q000494:pharmacology* / Q000627:therapeutic use; D001794:Blood Pressure / Q000187:drug effects; D002395:Catecholamines / Q000652:urine*; D003864:Depression, Chemical; D005260:Female; D006801:Humans; D006929:Hyperaldosteronism / Q000503:physiopathology; D006973:Hypertension / Q000188:drug therapy / Q000503:physiopathology*; D006977:Hypertension, Renal / Q000503:physiopathology; D007093:Imidazoles / Q000008:administration & dosage / Q000494:pharmacology* / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D011674:Pulse / Q000187:drug effects; D012083:Renin / Q000097:blood*; D012964:Sodium / Q000494:pharmacology; D013564:Sympathetic Nervous System / Q000187:drug effects
D000959:Antihypertensive Agents; D002395:Catecholamines; D007093:Imidazoles; D000450:Aldosterone; D012964:Sodium; D012083:Renin